In December 2022, the American College of Medical Genetics and Genomics made a recommendation that all expectant mothers should be offered non-invasive prenatal testing (NIPT) instead of traditional ...
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific (EUFI.PA) (Paris:ERF), a global leader in bio-analytical testing, announces that it has closed the acquisition of GATC Biotech AG ...
A team of investigators from Massachusetts General Hospital (MGH), Brigham and Women's Hospital (BWH), and the Broad Institute of MIT and Harvard have developed a non-invasive genetic test that can ...
Imagine this: You just found out that you or your partner are pregnant, and your overwhelmed with emotions. You start thinking about prenatal vitamins, making your first provider appointment, car ...
11d
Natera Launches EDEN Study on Early Risk Assessment for Preeclampsia and Adverse Pregnancy Outcomes
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the launch of EDEN, a large, multi-center prospective study designed to evaluate the company’s non ...
A team of investigators from Massachusetts General Hospital (MGH), Brigham and Women's Hospital (BWH), and the Broad Institute of MIT and Harvard have developed a non-invasive genetic test that can ...
MANCHESTER, England & BOGOTÁ, Colombia--(BUSINESS WIRE)--Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics ...
This diagnostics firm delivers precision molecular testing for prenatal and oncology use to hospitals and research centers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results